Soneath Lang Hang Pond, MD | |
1302 Elmwood Ave, Cranston, RI 02910-2201 | |
(401) 780-0600 | |
(401) 780-0844 |
Full Name | Soneath Lang Hang Pond |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 1302 Elmwood Ave, Cranston, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851460372 | NPI | - | NPPES |
04-06646 | Other | RI | UNITED HEALTH CARE |
2625 | Other | RI | NEIGHBORHOOD HEALTH PLAN |
25992-9 | Other | RI | BLUE CROSS |
405534 | Other | RI | BLUE CHIP |
25992-9 | Other | RI | LIFESPANBLUE |
406179 | Other | RI | TUFTS |
9002754 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 10102 (Rhode Island) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Conviva Medical Center Management, Llc | 4284717422 | 354 |
News Archive
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.
Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth.
› Verified 1 days ago
Entity Name | Conviva Medical Center Management, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649324278 PECOS PAC ID: 4284717422 Enrollment ID: O20080212000415 |
News Archive
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.
Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Soneath Lang Hang Pond, MD 1302 Elmwood Ave, Cranston, RI 02910-2201 Ph: (401) 780-0600 | Soneath Lang Hang Pond, MD 1302 Elmwood Ave, Cranston, RI 02910-2201 Ph: (401) 780-0600 |
News Archive
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events.
NTNU Professors May-Britt and Edvard Moser have been selected for the 2011 Anders Jahre's Award for Medical Research. The award, which includes a NOK 1 million (€128,000) prize, is considered among the most prestigious of medical awards in the Nordic countries.
The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.
Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth.
› Verified 1 days ago
Susan H Hart, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-275-5039 | |
Thomas Henry Mcgreen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 Fax: 401-946-8480 | |
Dr. Gregory G Allen, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1681 Cranston St, Suite D, Cranston, RI 02920 Phone: 401-946-8446 Fax: 401-946-8340 | |
Dr. Robert L Graves, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1150 Reservoir Ave, Suite 304, Cranston, RI 02920 Phone: 401-942-3330 Fax: 401-942-3833 | |
Dr. Robert John Bierwirth, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 | |
Dr. Steven Michael Sepe, M.D., PH.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 Belle Isle Way, Cranston, RI 02921 Phone: 401-942-7843 Fax: 401-942-7843 | |
Ms. Jun O Parks, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Budlong Rd, Cranston, RI 02920 Phone: 401-943-4530 |